News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
314,916 Results
Type
Article (9809)
Company Profile (115)
Press Release (304992)
Section
Business (107576)
Career Advice (637)
Deals (18675)
Drug Delivery (22)
Drug Development (36241)
Employer Resources (42)
FDA (5194)
Job Trends (6334)
News (167120)
Policy (10869)
Tag
Academia (575)
Alliances (23334)
Alzheimer's disease (516)
Approvals (5189)
Artificial intelligence (42)
Bankruptcy (125)
Best Places to Work (4951)
Biotechnology (110)
Breast cancer (91)
Cancer (749)
Career advice (554)
CAR-T (42)
Cell therapy (157)
Clinical research (29351)
Collaboration (228)
Compensation (123)
COVID-19 (695)
C-suite (81)
Data (730)
Diabetes (58)
Diagnostics (2514)
Earnings (45957)
Employer resources (43)
Events (55516)
Executive appointments (258)
FDA (5468)
Funding (209)
Gene therapy (69)
GLP-1 (192)
Government (788)
Healthcare (6257)
Infectious disease (727)
Inflammatory bowel disease (58)
Interviews (68)
IPO (9389)
Job creations (1614)
Job search strategy (513)
Layoffs (127)
Legal (2803)
Lung cancer (108)
Lymphoma (47)
Manufacturing (92)
Medical device (4128)
Medtech (4129)
Mergers & acquisitions (9433)
Metabolic disorders (153)
Neuroscience (676)
NextGen Class of 2024 (2316)
Non-profit (972)
Northern California (986)
Obesity (82)
Opinion (63)
Parkinson's disease (81)
People (33190)
Phase I (10229)
Phase II (13157)
Phase III (8990)
Pipeline (338)
Postmarket research (796)
Preclinical (4033)
Press Release (72)
Radiopharmaceuticals (143)
Rare diseases (94)
Real estate (2890)
Regulatory (7761)
Research institute (622)
Resumes & cover letters (88)
Southern California (806)
Startups (1717)
United States (7928)
Vaccines (107)
Date
Today (1)
Last 7 days (312)
Last 30 days (1181)
Last 365 days (18398)
2024 (18316)
2023 (20956)
2022 (27587)
2021 (28893)
2020 (25336)
2019 (18527)
2018 (14324)
2017 (14808)
2016 (13611)
2015 (16832)
2014 (13072)
2013 (10577)
2012 (11481)
2011 (12187)
2010 (11740)
Location
Africa (285)
Arizona (64)
Asia (18476)
Australia (3175)
California (2129)
Canada (816)
China (147)
Colorado (61)
Connecticut (92)
Europe (38700)
Florida (237)
Illinois (170)
Indiana (102)
Japan (52)
Maryland (274)
Massachusetts (1708)
Michigan (120)
Minnesota (147)
New Jersey (578)
New York (567)
North Carolina (406)
Northern California (986)
Ohio (60)
Pennsylvania (472)
South America (432)
Southern California (806)
Texas (255)
Utah (46)
Washington State (294)
314,916 Results for "pds biotechnology corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
PDS Biotechnology Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - December 6, 2024
December 9, 2024
·
5 min read
Business
PDS Biotechnology Announces Conference Call and Webcast for Business Update and Full Year 2023 Financial Results
PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a clinical-stage immunotherapy company developing a growing pipeline of targeted cancer immunotherapies and infectious disease vaccines based on the Company’s proprietary T cell-activating platforms, today announced that the Company will provide a business update and release financial results for the year ended December 31, 2023, on Wednesday, March 27, 2024.
March 20, 2024
·
6 min read
Press Releases
PDS Biotech to Participate at BTIG Virtual Biotechnology Conference
July 29, 2024
·
6 min read
Business
PDS Biotech Provides Business Update and Reports First Quarter 2024 Financial Results
PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused on transforming how the immune system targets and kills cancers and the development of infectious disease vaccines, today provided a business update and reported financial results for the first quarter of 2024.
May 15, 2024
·
11 min read
Business
PDS Biotech Appoints Stephan Toutain as Chief Operating Officer
PDS Biotechnology Corporation announced the appointment of Stephan Toutain, MS, MBA, as Chief Operating Officer, effective as of May 1, 2024.
May 2, 2024
·
8 min read
Drug Development
PDS Biotech Provides Data Update from Ongoing VERSATILE-002 Phase 2 Clinical Trial in Head and Neck Cancer
PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”),VERSATILE-002 is a late-stage immunotherapy company focused on transforming how the immune system targets and kills cancers and the development of infectious disease vaccines, today provided a data update from its ongoing VERSATILE-002 Phase 2 clinical trial.
June 12, 2024
·
8 min read
Business
PDS Biotech to Announce First Quarter 2024 Financial Results on May 15, 2024
PDS Biotechnology Corporation announced that the Company will report financial results for the first quarter of 2024 and provide a business update on Wednesday, May 15, 2024, before the market opens.
May 7, 2024
·
7 min read
Drug Development
PDS Biotechnology Announces Details of Virtual KOL EventVirtual Webinar Updated VERSATILE-002 Phase 2 Trial Results, Unmet Treatment Needs in Advanced Head and Neck Cancer and Planned Triple Combination Trial to be held May 8, 2024
PDS Biotechnology Corporation announced additional details of its virtual Key Opinion Leader event to be held on Wednesday, May 8, 2024 at 1:30 PM ET.
May 3, 2024
·
10 min read
Pharm Country
PDS Biotech to Participate in Upcoming May 2024 Investor Conferences
PDS Biotechnology Corporation, a late-stage immunotherapy company focused on transforming how the immune system targets and kills cancers and the development of infectious disease vaccines, announced that the Company will participate in two upcoming investor conferences taking place in May 2024.
May 9, 2024
·
6 min read
Pharm Country
PDS Biotech VERSATILE-002 Phase 2 Clinical Trial Meets Primary Study Endpoints in First Line Recurrent/Metastatic HPV16-Positive Head and Neck Cancer
PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”) hosted a Key Opinion Leader event on May 8, 2024 during which prominent experts in head and neck squamous cell cancer (“HNSCC”) discussed positive, updated VERSATILE-002 data and the unmet need in HPV16-positive HNSCC.
May 9, 2024
·
7 min read
1 of 31,492
Next
